The global aesthetic devices market is estimated to garner significant revenue by growing at a CAGR of ~10% over the forecast period, i.e., 2022 – 2030. The growth of the market is attributed to technological advancements in aesthetic devices, and surge in demand for aesthetic surgeries on the back of increasing geriatric population and rise in the number of individuals with obesity. According to International Society of Aesthetic Plastic Surgery (ISAPS), in 2019, a total of 11,363,569 surgical aesthetic procedures & 13,618,735 non-surgical aesthetic procedures were performed globally.
Furthermore, increasing preference towards minimally invasive procedures to obtain desired results with minimum complications, lesser recovery time, and least need for hospital admissions are fostering the growth of the market. As per ISAPS 2019 statistics, the major non-surgical aesthetic procedures performed globally included botulinum toxin, hyaluronic acid, hair removal, nonsurgical fat reduction, and photo rejuvenation.
However, high treatment cost and risk of complications related to certain implants due to unexpected reactions to anesthesia or having health issues such as diabetes, high body mass index, HIV, and others are likely to restrain the growth of the market.
The market is segmented by product type into aesthetic laser & energy devices, skin tightening & body contouring devices, facial aesthetic devices, and aesthetic implants, out of which, the aesthetic implants segment is anticipated to hold the largest market share owing to increasing demand for dental and breast implant procedures and the high durability of implant procedures. In 2019, a total of 229,680 breast implant procedures were performed worldwide, which was an increase of 10.7% from that of 2018.
On the basis of application, the market is segmented into skin resurfacing and tightening, body contouring and cellulite reduction, facial aesthetic procedures, breast augmentation, and others, out of which, the breast augmentation segment is estimated to grow at the highest rate over the forecast period and hold the largest market share. Breast augmentation placing breast implants under breast tissue or chest muscles to increase breast size. The growth of the segment can be attributed to technological development and growing novel product launches, and replacement of breast tissue due to cancer or breast abnormalities and its utilization in revision surgeries. CLICK TO DOWNLOAD SAMPLE REPORT
According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.
Geographically, the global aesthetic devices market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. North America is expected to hold the largest market share owing to rapid advancement of aesthetic technology in the region, and growing awareness for aesthetic procedures and adoption of non-invasive procedures. According to American Society of Plastic Surgeons (ASPS), about 15.6 million cosmetic procedures were performed in the U.S. in 2020, out of which, the top five procedures included nose reshaping, eyelid surgery, facelift, liposuction, and breast augmentation.
Asia-Pacific region is projected to witness growth at the highest rate over the forecast period owing to growing population with increasing disposable income. According to the World Bank data, the population in South Asia region increased from 1.391 Billion in 2000 to 1.857 Billion in 2020, while statistics by Organisation for Economic Co-operation and Development (OECD) state that the net annual growth rate of household disposable income in Japan, Korea, New Zealand, and Australia were 0.6%, 3.2%. 4.0%, and 4.5% respectively in 2020. Moreover, the region is witnessing exploding demand for cosmetic procedures over rising number of aesthetic procedure practitioners, which is expected to further foster the growth of the market. According to data reported by the International Society of Aesthetic Plastic Surgery (ISAPS), total aesthetic procedures performed in Japan, India, and Thailand in the year 2019 were 1,473,221, 643,752, and 123,228 respectively.
The global aesthetic devices market is further classified on the basis of region as follows:
Our in-depth analysis of the global aesthetic devices market includes the following segments:
FREQUENTLY ASKED QUESTIONS
Technological advancements in aesthetic devices, and surge in demand for aesthetic surgeries on the back of increasing geriatric population and rise in the number of individuals with obesity are the major factors driving the market growth of the global aesthetic devices market.
The market is anticipated to attain a CAGR nearly 10% over the forecast period, i.e., 2022-2030.
High treatment cost and risk of complications related to certain implants are estimated to hamper the market growth.
Asia-Pacific region is expected to provide significant business opportunities for the growth of the market.
The major players in the market are Alma Lasers, Bausch Health Companies Inc., Johnson & Johnson Services, Inc., Cynosure, Allergan Aesthetics (AbbVie), El.En. S.p.A, Cutera, Sciton, Inc., Candela Medical, Galderma Laboratories, L.P., and others.
The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
The market is segmented by product type, application, end-user, and by region.
The aesthetic implants segment is anticipated to hold largest market size in value and witness a modest growth over the forecast period.
Select License Type
Direct access to analyst to help you understand the market in a better way to handle your critical question
Citing your business specific requirement our consultant would assist you ensuring targeted goal is achieved
Get 10% free customization